Citigroup Maintains Neutral on 23andMe Holding, Lowers Price Target to $0.47
BenzingaApr 16 22:40
23andMe Holding Analyst Ratings
BenzingaApr 16 22:26
Citi: Maintains 23andMe Holding (ME.US) rating, adjusted from neutral to neutral, and adjusted the target price from $0.85 to $0.47.
Zhitong FinanceApr 16 22:40
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and 23andMe Holding (ME)
TipRanksApr 16 08:40
Analysts Conflicted on These Healthcare Names: Denali Therapeutics (DNLI), BridgeBio Pharma (BBIO) and 23andMe Holding (ME)
TipRanksFeb 8 19:20
Buy Rating for 23andMe on Strategic Restructuring and Potential for Shareholder Value Enhancement
TipRanksFeb 8 09:55
Maintaining a Hold: Balancing 23andMe's Innovative Therapeutic Prospects With Early-Stage Development Risks
TipRanksFeb 1 14:06
Balancing Potential and Risk: Hold Rating on 23andMe Amid Clinical Trial Developments
TipRanksDec 19, 2023 23:46
Citi Keeps Their Hold Rating on 23andMe Holding (ME)
TipRanksNov 13, 2023 07:46
Analysts Conflicted on These Healthcare Names: Sana Biotechnology (SANA), 23andMe Holding (ME) and Invitae (NVTA)
TipRanksNov 9, 2023 12:20
Analysts Conflicted on These Healthcare Names: 23andMe Holding (ME), Tenet Healthcare (THC) and Revvity (RVTY)
TipRanksOct 31, 2023 18:20
Hold Rating on 23andMe Amid Anticipation of Crucial Cancer Therapy Data Presentation
TipRanksSep 28, 2023 18:43
Citigroup Maintains Buy on 23andMe Holding, Lowers Price Target to $1.75
BenzingaAug 10, 2023 23:59
23andMe Holding Analyst Ratings
BenzingaAug 10, 2023 23:57
Citi Keeps Their Hold Rating on 23andMe Holding (ME)
TipRanksAug 10, 2023 18:26
Berenberg Bank Keeps Their Buy Rating on 23andMe Holding (ME)
TipRanksAug 9, 2023 09:25
Berenberg Bank Sticks to Its Buy Rating for 23andMe Holding (ME)
TipRanksJul 21, 2023 03:25
Citigroup Adjusts 23andMe Price Target to $2.50 From $3.75, Maintains Neutral Rating
MT NewswiresMay 26, 2023 20:46
Credit Suisse Reiterates Outperform on 23andMe Holding, Maintains $6 Price Target
BenzingaMay 26, 2023 19:53
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Relay Therapeutics (RLAY) and 23andMe Holding (ME)
TipRanksApr 19, 2023 09:30
No Data
No Data